Local view for "http://purl.org/linkedpolitics/eu/plenary/2000-04-11-Speech-2-279"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20000411.10.2-279"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Mr President, I shall start with the second part of Mrs Breyer's question. It is true that there is no specific Community legislation for the contained use of genetically modified plants and animals. However, Article 2(4) of the common position obliges Member States to ensure that these GMOs are handed over to a third party only if stringent containment measures are in place, otherwise notification under Part C of the directive is necessary. Amendment No 42 would prevent any exchange of genetically modified plants and animals for research activities under contained use until Community legislation is in force. That is why we cannot accept Amendment No 42.
As you know, we have now issued a White Paper on environmental liability. It is now open for comments and views and we are ready to discuss it because I want to ensure that this environmental liability paper covers GMOs. Your views are also welcome. I intend to ensure that this paper covers GMOs. It already covers product liability. Insurance is one thing we will have to look into in more depth and also get the views of other parties on the practical aspects. The White Paper is a first step, as you know. That has to be discussed in depth and I will come back with a proposal. I believe it will be possible to put an insurance system in place."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples